BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12044305)

  • 1. Pediatric visceral leishmaniasis in Albania.
    Lita G; Davachi F; Sulcebe G; Bregu H; Basha M
    Int J Infect Dis; 2002 Mar; 6(1):66-8. PubMed ID: 12044305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1,210 consecutive hospitalized patients (1995-2009).
    Petrela R; Kuneshka L; Foto E; Zavalani F; Gradoni L
    PLoS Negl Trop Dis; 2010 Sep; 4(9):. PubMed ID: 20838650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.
    Silveira LJ; Rocha TJ; Ribeiro SA; Pedrosa CM
    Rev Inst Med Trop Sao Paulo; 2015; 57(1):33-8. PubMed ID: 25651324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
    Dursun O; Erişir S; Yeşilipek A
    Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric visceral leishmaniasis in southern France.
    Minodier P; Piarroux R; Garnier JM; Unal D; Perrimond H; Dumon H
    Pediatr Infect Dis J; 1998 Aug; 17(8):701-4. PubMed ID: 9726344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.
    Arik Yilmaz E; Tanir G; Tuygun N; Taylan Ozkan A
    Turkiye Parazitol Derg; 2009; 33(4):259-62. PubMed ID: 20101572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
    Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
    AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of visceral leishmaniasis in children in the Central-West Region of Brazil.
    Brustoloni YM; Cunha RV; Cônsolo LZ; Oliveira AL; Dorval ME; Oshiro ET
    Infection; 2010 Aug; 38(4):261-7. PubMed ID: 20508967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of acute lymphoblastic leukaemia and visceral leishmaniasis].
    Nafil H; Tazi I; Mahmal L
    Ann Biol Clin (Paris); 2011; 69(6):729-31. PubMed ID: 22123576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.
    Sayyahfar S; Ansari S; Mohebali M; Behnam B
    Korean J Parasitol; 2014 Apr; 52(2):189-91. PubMed ID: 24850963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
    Tachfouti N; Najdi A; Alonso S; Sicuri E; Laamrani El Idrissi A; Nejjari C; Picado A
    PLoS One; 2016; 11(6):e0155482. PubMed ID: 27257808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
    Utili R; Rambaldi A; Tripodi MF; Andreana A
    Infection; 1995; 23(3):182-3. PubMed ID: 7499009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Visceral childhood leishmaniasis: diagnosis and treatment].
    Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
    An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
    Kuyucu N; Kara C; Bakirtaç A; Teziç T
    Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis in District Dir, NWFP.
    Rahim F; Rehman F; Ahmad S; Zada B
    J Pak Med Assoc; 1998 Jun; 48(6):161-2. PubMed ID: 9813985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
    Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
    [No Abstract]   [Full Text] [Related]  

  • 18. Visceral leishmaniasis in a Brazilian child infected perinatally with human immunodeficiency virus.
    Ferreira E; Lucena S; Fonseca G; Barbosa TC; Aquino RB; Lambert JS; Nogueira SA
    Pediatr Infect Dis J; 2001 Feb; 20(2):224-6. PubMed ID: 11224850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kala azar with disseminated dermal leishmaniasis.
    Kumar PV; Sadeghi E; Torabi S
    Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
    Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.